Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys-Reference-Cited by-同舟云学术

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys

Published:2017-04-20 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Losen Mario^ORCID,Labrijn Aran F.^ORCID,van Kranen-Mastenbroek Vivianne H.,Janmaat Maarten L.,Haanstra Krista G.^ORCID,Beurskens Frank J.,Vink Tom,Jonker Margreet,‘t Hart Bert A.,Mané-Damas Marina,Molenaar Peter C.,Martinez-Martinez Pilar,van der Esch Eline,Schuurman Janine^ORCID,de Baets Marc H.,Parren Paul W. H. I.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-01019-5.pdf

Reference63 articles.

1. Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. & Duane, D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26, 1054–1059 (1976).

2. Engel, A. G. & Arahata, K. The membrane attack complex of complement at the endplate in myasthenia gravis. Ann N Y Acad Sci 505, 326–332, doi: 10.1111/j.1749-6632.1987.tb51301.x (1987).

3. Sahashi, K., Engel, A. G., Lambert, E. H. & Howard, F. M. Jr. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol 39, 160–172, doi: 10.1097/00005072-198003000-00005 (1980).

4. Drachman, D. B., Angus, C. W., Adams, R. N., Michelson, J. D. & Hoffman, G. J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298, 1116–1122, doi: 10.1056/NEJM197805182982004 (1978).

5. Mitra, A. K., McCarthy, M. P. & Stroud, R. M. Three-dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 A by low dose electron microscopy and x-ray diffraction to 12.5 A. J Cell Biol 109, 755–774, doi: 10.1083/jcb.109.2.755 (1989).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New, Old, and Shared Antibody Specificities in Autoimmune Diseases;Antibodies;2024-03-13

2. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities;Acta Neuropathologica;2022-09-08

3. Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders;Autoimmunity Reviews;2022-07

4. Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies;Antibodies;2020-09-23

5. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture;Cells;2019-07-02